Αποτελέσματα Αναζήτησης
Observational and Clinical Outcomes Researcher, Effective Team Leader · Accomplished Research Director with significant experience in Pharmaceutical and Healthcare clinical research,...
Lincy LAL | Cited by 1,148 | of University of Texas Health Science Center at Houston, Texas | Read 165 publications | Contact Lincy LAL
View the profiles of professionals named "Lincy Lal" on LinkedIn. There are 3 professionals named "Lincy Lal", who use LinkedIn to exchange information, ideas, and opportunities.
Lincy S. Lal, PhD, PharmD Director, Therapeutic Lead, Oncology Dr. Lincy Lal joined Optum in 2016. As therapeutic lead of oncology, Dr. Lal provides oversight of opportunities and studies in this area, including development of opportunities and coordination of clinical and scientific input. Dr. Lal has particular experience in
11 Σεπ 2020 · Second-line treatment for immune thrombocytopenia (ITP) is not well reported for patients treated in real-world clinical settings. The purpose of this study was to compare outcomes of four second-line treatments for ITP.
View the profiles of people named Lincy Lal. Join Facebook to connect with Lincy Lal and others you may know. Facebook gives people the power to share...
2 Ιουν 2022 · Lincy S. Lal et al., Comparison of DNA sequencing, immunohistochemistry, and in-situ hybridization techniques to determine HER2 status in metastatic breast cancer patients.. JCO 40 , e13045-e13045 (2022).
